Fengling Yang

4.3k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

Fengling Yang is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Fengling Yang has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Fengling Yang's work include Gut microbiota and health (5 papers), Dermatology and Skin Diseases (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Fengling Yang is often cited by papers focused on Gut microbiota and health (5 papers), Dermatology and Skin Diseases (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Fengling Yang collaborates with scholars based in China, Belgium and United States. Fengling Yang's co-authors include Lanjuan Li, Yanfei Chen, Yunbo Chen, Haifeng Lu, Baoli Zhu, Yuezhu Wang, Baohong Wang, Dajiang Lei, Min Xu and Li Shao and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Bacteriology.

In The Last Decade

Fengling Yang

22 papers receiving 1.2k citations

Hit Papers

Characterization of fecal microbial communities in patien... 2011 2026 2016 2021 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengling Yang China 10 762 547 282 249 198 27 1.2k
Baohong Wang China 10 663 0.9× 453 0.8× 252 0.9× 174 0.7× 152 0.8× 13 987
Huiyong Jiang China 21 843 1.1× 380 0.7× 163 0.6× 177 0.7× 265 1.3× 64 1.5k
Phillipp Hartmann United States 20 1000 1.3× 978 1.8× 254 0.9× 404 1.6× 149 0.8× 47 1.8k
Razan Alkhouri United States 10 1.2k 1.5× 1.1k 2.0× 140 0.5× 722 2.9× 137 0.7× 19 2.1k
Kaicen Wang China 24 759 1.0× 264 0.5× 88 0.3× 188 0.8× 217 1.1× 44 1.3k
Liya Yang China 24 1.1k 1.5× 342 0.6× 95 0.3× 227 0.9× 242 1.2× 40 1.7k
Marta Llopis Spain 16 1.2k 1.6× 641 1.2× 96 0.3× 481 1.9× 276 1.4× 23 1.9k
Xiaoyuan Bian China 20 985 1.3× 311 0.6× 74 0.3× 210 0.8× 206 1.0× 33 1.5k
Perttu Arkkila Finland 10 484 0.6× 369 0.7× 92 0.3× 121 0.5× 302 1.5× 18 927
Xianwan Jiang China 17 798 1.0× 239 0.4× 79 0.3× 156 0.6× 178 0.9× 20 1.1k

Countries citing papers authored by Fengling Yang

Since Specialization
Citations

This map shows the geographic impact of Fengling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengling Yang more than expected).

Fields of papers citing papers by Fengling Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengling Yang. The network helps show where Fengling Yang may publish in the future.

Co-authorship network of co-authors of Fengling Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengling Yang. A scholar is included among the top collaborators of Fengling Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengling Yang. Fengling Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jing, et al.. (2025). NO reduction performance of pyrolyzed biomass char: Effects of dechlorination removal pretreatments. Chinese Journal of Chemical Engineering. 80. 119–129.
2.
Yang, Fengling, et al.. (2025). Efficacy and Safety of Adalimumab and Secukinumab in Erythrodermic Psoriasis: A Single Centre Retrospective Study. Indian Journal of Dermatology. 70(4). 221–221.
3.
Zhao, Bing, Yao Wang, Zi Shi, et al.. (2025). Identification and application of herbicide‐resistant 4‐hydroxyphenylpyruvate dioxygenase (HPPD) alleles via directed evolution. Plant Biotechnology Journal. 23(10). 4336–4338.
4.
Wang, Yachen, et al.. (2024). Paradoxical psoriasis induced by IL-17 antagonists. Indian Journal of Dermatology Venereology and Leprology. 90(5). 623–631. 3 indexed citations
6.
Wu, Ling, Yongfang Wang, Zhaozhi Wang, et al.. (2023). Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling. Frontiers in Pharmacology. 14. 1200843–1200843. 24 indexed citations
7.
Li, Taotao, Bingbing Li, Chunli Liao, et al.. (2022). Transcriptome analysis provides insights into light condition effect on paclitaxel biosynthesis in yew saplings. BMC Plant Biology. 22(1). 577–577. 9 indexed citations
8.
Yang, Fengling, Yun Zheng, & Gang Li. (2020). Early Prelingual Auditory Development of Infants and Toddlers With Unilateral Hearing Loss. Otology & Neurotology. 41(5). 654–0. 7 indexed citations
9.
Yang, Fengling, Fei Zhao, Yun Zheng, & Gang Li. (2020). Modification and verification of the Infant–Toddler Meaningful Auditory Integration Scale: a psychometric analysis combining item response theory with classical test theory. Health and Quality of Life Outcomes. 18(1). 367–367. 8 indexed citations
10.
Shao, Li, Zongxin Ling, Deying Chen, et al.. (2018). Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study. Frontiers in Microbiology. 9. 3166–3166. 64 indexed citations
11.
Xing, Jing, Rukang Zhang, Xiangrui Jiang, et al.. (2018). Rational design of 5-((1H-imidazol-1-yl)methyl)quinolin-8-ol derivatives as novel bromodomain-containing protein 4 inhibitors. European Journal of Medicinal Chemistry. 163. 281–294. 18 indexed citations
12.
Ren, Jianjun, Yu Zhao, Dan Lv, et al.. (2018). Immunomodulatory effect of Bifidobacterium�breve on experimental allergic rhinitis in BALB/c mice. Experimental and Therapeutic Medicine. 16(5). 3996–4004. 24 indexed citations
13.
Hu, Xinjun, Hua Zhang, Hai‐Feng Lü, et al.. (2016). The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus. PLoS ONE. 11(3). e0151976–e0151976. 17 indexed citations
14.
Liu, Ya, Zhaoxu Gao, Wen Ren, et al.. (2015). RNA-Seq Analysis Reveals MAPKKK Family Members Related to Drought Tolerance in Maize. PLoS ONE. 10(11). e0143128–e0143128. 41 indexed citations
15.
Chen, Yanfei, Nan Qin, Jing Guo, et al.. (2014). Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis. BMC Genomics. 15(1). 753–753. 35 indexed citations
16.
Yang, Fengling, et al.. (2014). Longitudinal Results of Intratympanic Injection of Budesonide for Otitis Media With Effusion in Children Over 12 Years and Adults. Otology & Neurotology. 35(4). 629–634. 7 indexed citations
17.
Yang, Fengling, et al.. (2013). [The clinical study of eight cases of nasal solitary keratoacanthoma].. PubMed. 27(23). 1337–8. 1 indexed citations
18.
Yang, Fengling, et al.. (2013). [Four cases of extraskeletal Ewing's sarcoma in the head and neck and literature review].. PubMed. 27(18). 1000–2, 1005. 2 indexed citations
19.
Chen, Yanfei, Fengling Yang, Haifeng Lu, et al.. (2011). Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 54(2). 562–572. 801 indexed citations breakdown →
20.
Xu, Min, Baohong Wang, Yiqi Fu, et al.. (2011). Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease. Microbial Ecology. 63(2). 304–313. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026